High concentrations of caffeine and taurine are key constitutes of many ergogenic supplements 30 ingested acutely to provide legal enhancements in athlete performance. Despite this, there is little 31 evidence supporting the performance enhancing effects of acute taurine supplementation. In vitro 32 models have demonstrated that a caffeine induced muscle contracture can be further potentiated 33 when combined with a high concentration of taurine. However, the high concentration of caffeine 34 used in previous research would be toxic for human consumption. Therefore the present study aims 35 to investigate the direct effect of a physiological dose of caffeine and taurine to potentiate skeletal 36 muscle performance. Isolated mouse soleus muscle was used to examine the effects of physiological 37 taurine (TAU), caffeine (CAF), and taurine-caffeine combined (TC) on: 1) acute muscle power output; 38
Introduction 51
The ergogenic effect of energy drinks to promote legal enhancements in sporting performance is 52 largely attributed to high concentrations of caffeine due to the corresponding wealth of evidence 53 demonstrating positive effects across endurance, power and strength activities (Alford et al. 2001 ; 54 Davis & Green, 2009; Duncan & Oxford, 2011; Graham et al. 2001,) . In addition to high 55 concentrations of caffeine and various sugars, the amino acid taurine (Amino Ethane Sulfonic Acid) is 56 a constituent of many energy drinks and is believed to contribute to the performance enhancing 57 effect (Geib et al. 1994) . Despite this there is little evidence to demonstrate an acute ergogenic 58 effect of taurine. 59
Found in high concentrations in mammalian tissue, taurine is readily synthesized by the body and 60 although the exact mechanisms of action are unclear, evidence suggests relationships to the 61 functions of osmoregulation, regulation of oxidative stress, and cell signalling (Cuisinier et demonstrate that the almost complete depletion of skeletal muscle taurine reduced exercise 66 capacity by over 80%. Reducing the intracellular concentration of taurine has commonly been shown 67 to result in a reduction in skeletal muscle function, primarily resulting in a decrease in muscle force 68 production (Hamilton et al. 2006) . Evidence is also presented to suggest that depletion of muscular 69 taurine occurs during prolonged muscle activation ; Matsuzaki et al. 2002) , therefore 70 suggesting a link between fatigue and muscular taurine concentration. 71
In vivo and in vitro evidence suggests that chronic taurine supplementation can positively enhance 72 skeletal muscle performance (Imagawa et al. 2009 ). Chronic taurine supplementation in rats has 73 been shown to lead to large increases in muscle taurine concentration and a consequential 74 enhancement of muscle force. This in turn has been shown to correspond to an increase in SR Ca The present study aims to uniquely assess if an acute physiological dose of taurine is sufficient to 95 improve muscular power and offset fatigue, and is the first to determine whether the ergogenic 96 effect of caffeine is augmented when combined with taurine when both are at a physiological 97 concentration. This research uses the work look technique as a closer representation of in vivo 98 muscle performance to compare the direct effects of physiologically relevant concentrations of 99 taurine alone (2.64mM), caffeine alone (70µM), and taurine and caffeine combined on: 1) acute 100 maximal muscle power output; 2) time to fatigue; 3) recovery following fatigue on isolated mouse 101 soleus muscle. 
Materials and Methods 118

Animals 119
The use of animals in this study was approved by the ethics committee of Coventry University. 120
Female white mice (strain CD1 mice, Charles River, UK) were bred and kept at Coventry University. 8 121 -10 week old mice (body mass = 31.1±0.24 g, mean ± SE, n =72) were weighed and then killed by 122 cervical dislocation in accordance with British Home Office Animals (Scientific Procedures) Act 1986, 123 Schedule 1. 124
Soleus muscle was isolated from the right hind limb and pinned out at approximately its resting 125 length at room temperature (19-21 o C). During dissection the muscle preparation was maintained in 126 cooled (refrigerated) and frequently changed oxygenated (95% O2; 5% CO2) Krebs-Henseleit solution 127 of composition (mM) NaCl 118; KCl 4.75; MgSO4 1.18; NaHCO3 24.8; KH2PO4 1.18; glucose 10; CaCl2 128 2.54; pH 7.55 (at room temperature prior to oxygenation). For each preparation, the tendon and a 129 small piece of bone was left attached at the proximal and distal ends. Aluminium foil T-clips were 130 wrapped around each tendon leaving the bone at the back of the clip to help minimise tendon 131 slippage when the muscle was producing force (James et al. 2005) . 132
133
Isometric Studies 134
Isometric studies were used to determine the twitch and tetanus kinetics of isolated mouse soleus 135 muscle. The foil clips at either end of the muscle preparation were clamped to a force transducer 136 force. In order to elicit a tetanus response the muscle was subjected to a 320ms burst of electrical 146 stimuli and stimulation frequency was optimised (usually 140Hz) to achieve maximal isometric 147 tetanus force. To ensure sufficient recovery a 5 minute rest period was imposed between each 148
tetanus. An eyepiece graticule fitted to a microscope was used to measure muscle length (defined as 149 L0); mean muscle fibre length was then calculated as 85% of L0 (James et al. 1995) . 150
151
Work Loop Analysis of Muscle Power Output 152
The work loop technique was used in order to determine muscle power output during cyclical length 153 changes (Josephson, 1985; James et al. 1996) . Muscle preparations were subjected to four sinusoidal 154 length change cycles at a strain of 0.10 around the previously determined L0 that generated maximal 155 isometric twitch and tetanus force. Therefore muscle lengthened by 5% from L0 followed by a 156 shortening to 5% shorter than L0 before returning back to L0. This occurred at a 5Hz cycle frequency 157 that had previously been determined to elicit maximal mouse soleus muscle power output and is 158 attainable in vivo (James et al. 1995) . The strain employed also comes from previous estimates of 159 maximal power output for mouse soleus muscle and again is attainable during in vivo locomotion 160 (James et al. 1995) . The stimulation frequency and amplitude found to yield maximal isometric force 161 were employed to stimulate the muscle during the shortening phase of the work loop. sampled at a rate of 10 kHz and then a work loop was formed, by plotting force against length, the 170 area of which represents the net work done by the muscle during a single length change cycle 171 (Josephson, 1985) . proportionately, the present study uses a taurine concentration of 2.64mM equating to 5.8g, similar 180 to maximal doses as previously outlined (5-6mg). 181
In order to test whether 2.64 mM of taurine alone (TAU) or 2.64 mM taurine and 70µM caffeine 182 combined (TC) affected acute muscle power output, time to fatigue, or recovery from fatigue, each 183 soleus muscle preparation was subjected to one of the following protocols. i.e. each muscle 184 preparation was used to determine the effects of treatment on acute power output or time to 185 fatigue or recovery from fatigue. 70µM is recognised as the human physiological maximum. The 186 caffeine only treatment data at this concentration has been published previously (Tallis et al. 2012 ; 187
2013). 188
Acute Power Output 189
In order to test the acute effect of a given treatment the muscle was subjected to 4 work loop cycles 190 at 10 minute intervals over 120 minutes. During the initial 3 measurements the muscle was was changed back to standard Krebs-Henseleit solution and recovery was monitored for 60 minutes. 208
The control protocol followed the same process however the muscle was maintained in standard 209
Krebs-Henseleit solution throughout. 210
211
Recovery from Fatigue 213
In order to measure the effects of taurine and/or caffeine on recovery from fatigue the same fatigue 214 protocol as above was used, however, in the time up to and inclusive of the fatigue run the muscle 215 was incubated in standard Krebs-Henseleit solution. Immediately after the fatigue run the solution 216 was changed to TAU, TC or Caffeine (CAF) and recovery was monitored for the next hour. 217 218
Muscle Mass Measurements and Dimension Calculations 219
At the end of the experiment the muscle was disconnected from the apparatus and the tendons and 220 bones removed leaving the muscle intact. Following this, the muscle was blotted on tissue paper to 221 remove excess fluid. The muscle was then placed on an electronic balance (Mettler Toledo B204-S, 222
Zurich, Switzerland) to determine the wet muscle mass. Mean muscle cross-sectional area was 223 calculated from mean fibre length, muscle mass and an assumed muscle density of 1060 kg m 
Statistical Analysis of Data 228
In order to compare the quality of muscle between treatment groups a single factor ANOVA was 229 conducted on maximal untreated isometric stress and work loop power output data. 230
Due to the gradual development of an anoxic core in control conditions muscle power output will 231 slowly decrease over time (Barclay, 2005 ). For the muscles tested in the present study power output 232 decreased to an average 96 ± 1% of initial power over the 120 minute duration of the work loop Initially, for the acute power output data, pre treatment controls were compared against post 240 treatment washout controls for each experimental group. There was no significant difference 241 between these control data (Fig 1; paired t-test, t<0 .5, P>0.6 in all cases) therefore, it was assumed 242 that any subsequent change in muscle power when incubated in TC, TAU or CAF was an effect of the 243 given treatment. In order to assess the effects of treatment for each acute response the control data 244
were compared directly against treatment data via paired t-tests. A single factor ANOVA was 245 conducted in order to identify whether the given increase in power output was different between 246 treatments (TC vs.TAU vs. CAF). Tukey post hoc tests were used to establish where these differences 247 
Results
278
Comparisons between stress and power were made using only the original data presented in this 279 study (i.e. n=76 out of the n=92 total). The mean maximal isometric twitch and tetanus stress for 280 soleus muscle (n=76) was 38.6 ± 1.5 kN m -2 and 219 ± 7 kN m -2 respectively. Mean untreated maximal 281 muscle power output was 32.8 ± 1 W kg -1 (n=76). Untreated mean maximal isometric tetanus stress 282 and work loop power output were not significantly different between experimental groups (single 283 factor ANOVA main effect F= 1.13 P=0.35 and F=0.33, P=0.95 respectively). Therefore, it is assumed 284 that the muscles were of a similar quality between the experimental groups and that any 285 subsequent differences in response occurred due to the effects of treatment. 
The Effect of Physiological Concentrations of Taurine and Caffeine on Muscle Power Output 297
Treatment of soleus muscle with caffeine alone and taurine-caffeine combined resulted in a 298 significant increase in acute maximal muscle power output of 6.4% and 4.1% respectively (Fig 1;  299 paired t-test, t<-2.29, P<0.03 in both cases) compared to controls. Treatment with taurine alone 300
The performance enhancing benefit was significantly dependant on treatment (Fig 1; single factor  302 ANOVA main effect F=3.59, P=0.03). There was no significant difference between the benefit 303 imposed by caffeine alone when compared with taurine and caffeine combined (Fig 1; Tukey  304 P=0.628). The treatment effect of caffeine was significantly higher than that of taurine alone (Fig 1;  305 Tukey P=0.027), however there was no significant difference between taurine and caffeine 306 combined and taurine alone (Fig 1; Tukey P=0.178) . 307
308
The Effect of Physiological Concentrations of Taurine and Caffeine on Time to Fatigue 309
The fatigue protocol was effective in inducing soleus muscle fatigue as power output reduced 310 significantly over time (Fig 2; two factor ANOVA main effect of time F=110, P<0.001). There was a 311 significant effect of treatment on time to net negative work (Fig 2; two factor ANOVA main effect 312
F=15.68, P<0.001). Treatment of soleus muscle with caffeine alone or with taurine and caffeine 313
combined resulted in a significantly decreased time to fatigue (time to net negative work decreased 314 by 30% and 15% respectively) compared to controls (Fig 2; Tukey P<0.001 in both cases). Soleus 315 muscle treated with caffeine fatigued significantly faster than muscle treated with taurine and 316 caffeine combined (Fig 2; Tukey P<0.001 ). There was no significant difference in time to fatigue 317 between soleus muscles treated with taurine alone compared to controls (Fig 2; Tukey P<0.001) . 318
Soleus muscle treated with caffeine produced significantly less power when compared with: muscle 319 treated with taurine from 3.2s onwards; controls from 3.6s onwards; taurine and caffeine combined 320 from 4.8s (Fig 2; Tukey P<0 .04 in all cases). There was no significant difference in the mean power 321 output at any time point between any other treatments (Fig 2; Tukey P>0.05 in all cases) . 322 323
The Effect of Physiological Concentrations of Taurine and Caffeine on Recovery from Fatigue 324
Power output significantly increased over time during recovery from fatigue (Fig 3; two factor  325 ANOVA main effect F=8.29, P<0.001). The level of soleus muscle recovery was not significantly 326 dependent on treatment (Fig 3; two factor ANOVA main effect F=2.59, P=0.054). Mean muscle 327 recovery for the entire group was 87% of the pre fatigue maximum and occurred between 80 and 90 328 minutes following the start of the work loop protocol (Fig 3) . Although during the latter stages of the 329 measured recovery period, muscles treated with taurine and caffeine combined appeared to have 330 reduced recovery, power output was not significantly different between treatments at any given 331 time point during the recovery period (Fig 3; As no increase in acute muscle power was reported in the present study, it is suggested that taurine 368 treatment failed to elicit improved skeletal muscle Ca 2+ handling. The current research uses a 369 physiologically relevant taurine concentration (2.64mM) which is much lower than that of previous 370 work (5-20mM) and uniquely examines treatment effects over dynamic muscle contraction, rather 371 than constant muscle length studies, which may also contribute to the differences in results. 372 Steele et al. (1990) reported that taurine concentrations greater than 1mM contributed to larger 373 caffeine induced (10mM) contracture of skinned rat heart tissue. This effect of taurine-caffeine 374 combined was not transferable to skeletal muscle in the present study when used at a physiological 375 level (70µM human maximal) of caffeine concentration and the combined effect was not greater 376 than that of caffeine alone in the present study. Besides the differences in caffeine concentration, 377 10mM caffeine would be highly toxic for human consumption (Fredholm et al. 1999) , it is considered 378 that the effects of taurine are more profound in heart tissue which may further contribute to the 379 differences in results (Schaffer et al. 2010) . 380
The caffeine induced increase in muscle power has been attributed to a greater release of Ca Treatment with 2.64mM of taurine failed to significantly affect the time to fatigue in maximally 388 stimulated mouse soleus muscle compared to controls. When taurine was combined with caffeine 389 time to fatigue was significantly decreased, although treatment of soleus muscle with caffeine alone 390 resulted in significantly faster time to fatigue than all other treatments. These results suggest that in 391 this instance, adding taurine to caffeine may in part block the effects of caffeine alone as the profile 392 of fatigue is shifted to the right with respect to the caffeine only treatment data (Fig 2) .
A reduction in skeletal muscle taurine content following prolonged muscle stimulation has 394 previously been established in vitro Matsuzaki et al. 2002) . Chronic 395 supplementation has been shown to significantly increase muscle taurine concentration resulting in 396 increased muscle force production and partially counteracting the effect of intramuscular taurine 397 depletion that occurs during fatigue (Goodman et concentration (Askew, 1997) . It is believed that this effect is amplified in the presence of caffeine 410 resulting in the muscle being active to a greater extent at the end of shortening, hence greater work 411 is required to stretch the muscle back to its resting length (Tallis et al. 2013 ). This provides a partial 412 explanation as to why TC fatigues faster than controls. Silva et al. (2011) demonstrated that chronic 413 supplementation of taurine in rats (1-ml 300 mg kg −1 per body weight) had a cytoprotective role in 414 exercise induced muscle injury. Although this mechanism is not ruled out by the authors it is unlikely 415 that the taurine concentration used in the present study will increase intramuscular taurine levels 416 enough to generate this mechanism. Moreover, Tallis et al. (2012) highlighted the diverse individual 417 acute response to 70µM caffeine and a clear division between responders and non-responders to 418 the treatment. The difference in time to fatigue between CAF and TC are most likely to be due to 419 individual differences in response to the caffeine treatment and the ratio of responders and non-420 responders between the treatment groups. This is partly supported in the present study by the 421 increase in standard error for the TC trial compared to CAF (Fig 2) . 
